| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
QDEL
QuidelOrtho
|
May 07, 2026 | HOLD |
Buy
+183.5% avg upside
13 analysts
|
$12.00
12.20% Downside
|
+21.9% |
|
VCYT
Veracyte
|
May 06, 2026 | BUY |
Strong Buy
-20.7% avg upside
17 analysts
|
$52.00
2.99% Downside
|
-6.6% |
|
WAT
Waters
|
May 06, 2026 | HOLD |
Strong Buy
+3.6% avg upside
30 analysts
|
$375.00
5.50% Upside
|
+2.1% |
|
DHR
Danaher
|
Apr 22, 2026 | BUY |
Strong Buy
+21.9% avg upside
45 analysts
|
$250.00
41.03% Upside
|
-3.4% |
|
FLGT
Fulgent Genetics
|
Mar 02, 2026 | BUY |
Buy
+142.6% avg upside
7 analysts
|
$22.00
22.19% Upside
|
+11.3% |
|
MYGN
Myriad Genetics
|
Feb 25, 2026 | HOLD |
Hold
+313.3% avg upside
24 analysts
|
$6.00
32.09% Upside
|
-18.2% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.